Publications Database

Angley M. T. et al. (2007)

Children and autism: Part 2: management with complementary medicines and dietary interventions.

Australian Family Physician

36(10), pp. 827-830

Read Abstract (New Window) Read Full (New Window)

Antonelli C. et al. (2009)

Guiding principles in choosing a therapeutic table for DCI hyperbaric therapy.

Minerva Anestesiol

75(3), pp. 151-161

Read Abstract (New Window)

Appleton R. E. et al. (2011)

Mends: the use of melatonin in children with neuro-developmental disorders and impaired sleep - a randomised, double-blind, placebo-controlled, parallel trial.

Archives of Disease in Childhood

96 A1

Read Abstract (New Window)

Arnold G. et al. (2003)

Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Journal of Autism and Developmental Disorders

33(4), pp. 449-454

Read Abstract (New Window)

British Dietetic Association (2006)

Dietitians raise alarm on alternative food allergy tests and dietary autism treatments.

London: British Dietetic Association

Read Full (New Window)

Autism Research Institute (2008)

Di-methyl-glycine (DMG).

San Diego: CA: Autism Research Institute

Autism Research Institute (2008)

Dimethylglycine (DMG) for autism.

San Diego: CA: Autism Research Institute

Autism Research Institute (1990)

Dimethylglycine (DMG), a nontoxic metabolite, and autism.

Autism Research Review International

4(2), p. 3

Auyeung B. et al. (2015)

Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.

Translational Psychiatry

e. 507

Read Abstract (New Window) Read Full (New Window)

Baker S. M. (2008)

Sidney MacDonald Baker, MD: taking a biomedical approach to autism treatment. Interview by Frank Lampe and Suzanne Snyder.

Alternative Therapies in Health and Medicine

14(6), pp. 60-69

Banov C. (1979)

Risks with controlling diet.

Journal of Autism and Developmental Disorders

9(1), pp. 135-136

Read Extract (New Window)

Barnes T. (1996)

The story of John: A little boy with autism.

International Review of Chiropractic

pp. 43-46

Read Full (New Window)

Barrett S. (2000)

Orthomolecular therapy.

Quackwatch

Read Full (New Window)

Barthélémy C. et al. (1981)

Behavioral and biological effects of oral magnesium, vitamin B6, and combined magnesium-B6 administration in autistic children.

Magnesium Bulletin

2 pp. 150-153

Bashir S. , Al-Ayadhi L. Y. (2014)

Effect of camel milk on thymus and activation-regulated chemokine (TARC) in autistic children: double blind study.

Pediatric Research

April, 75(4), pp. 559-556.

Read Abstract (New Window)

Baxter A. , Krenzelok E. (2008)

Pediatric fatality secondary to EDTA chelation.

Clin Toxicol (Phila).

46(10), pp. 1083-1084

Read Abstract (New Window) Read Full (New Window)

Becker M. M. et al.

Improvement in symptoms of autism spectrum disorder in children with the use of gastrin-releasing peptide: An open trial.

Clinical Neuropharmacology

Read Abstract (New Window)

Bell J. et al. (2004)

Essential fatty acids and phospholipase A2 in autistic spectrum disorders.

Prostaglandins, Leukotrienes and Essential Fatty Acids

71(4), 201-4

Read Abstract (New Window)

Bender D. A. (2011)

Vitamin B6: Beyond adequacy

Journal of Evidence-Based Complementary and Alternative Medicine

16 pp. 29-39

Read Abstract (New Window)

Bent S. et al. (2011)

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder.

Journal of Autism and Developmental Disorders

41(5), pp. 545-554.

Read Abstract (New Window) Read Full (New Window)